Last reviewed · How we verify
NCT06316310
Effect of Acupoint Thread Embedding on Obesity
NA trial testing acupoint thread embedding in Obesity in 132 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Shanghai Municipal Hospital of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 132 |
| Start date | 15 March 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- acupoint thread embedding
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Who can join
Adults 18 to 45, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators describe a protocol for a randomized controlled trial to find out the effect and safety of acupoint thread embedding on losing weight in obese patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect and safety of acupoint thread embedding in treatment of overweight and obese women: study protocol of a randomized controlled trial
Li X, Zhao Y, Gunes A, Li G, et al · · 2024 · DOI 10.21203/rs.3.rs-5671217/v1
Verify or expand the search:
- PubMed search for NCT06316310
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Shanghai Municipal Hospital of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07320456 — A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease · Phase 2 · not yet recruiting
- NCT07050563 — Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cance · NA · not yet recruiting
- NCT07050121 — A Prospective Multi-Center Real-World Study of Ciwujia Capsules in the Treatment of Cancer-Related Insomnia · not yet recruiting
- NCT07003763 — Electroacupuncture on Treating Cancer-related Depression · NA · recruiting
- NCT06442137 — A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06316310 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Municipal Hospital of Traditional Chinese Medicine
- Last refreshed: 11 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06316310.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing